TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,546,000 | +5.0% | 177,815 | 0.0% | 0.23% | +14.1% |
| Q4 2021 | $2,424,000 | -16.8% | 177,815 | 0.0% | 0.20% | -11.2% |
| Q3 2021 | $2,913,000 | -2.7% | 177,815 | 0.0% | 0.22% | +14.9% |
| Q2 2021 | $2,993,000 | -7.8% | 177,815 | 0.0% | 0.20% | +23.4% |
| Q1 2021 | $3,247,000 | -43.4% | 177,815 | -43.6% | 0.16% | -54.9% |
| Q4 2020 | $5,733,000 | +2.0% | 315,006 | 0.0% | 0.35% | -18.0% |
| Q3 2020 | $5,620,000 | -62.1% | 315,006 | -62.0% | 0.43% | -73.0% |
| Q2 2020 | $14,845,000 | +18.1% | 827,955 | 0.0% | 1.58% | -31.3% |
| Q1 2020 | $12,568,000 | -23.1% | 827,955 | 0.0% | 2.30% | +2.5% |
| Q4 2019 | $16,336,000 | +14.7% | 827,955 | 0.0% | 2.24% | +44.4% |
| Q3 2019 | $14,241,000 | -2.8% | 827,955 | 0.0% | 1.55% | +55.4% |
| Q2 2019 | $14,655,000 | -13.1% | 827,955 | 0.0% | 1.00% | -13.5% |
| Q1 2019 | $16,865,000 | – | 827,955 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |